Literature DB >> 10587919

Histopathologic variants of basal cell carcinoma correlation with sex, age and localization.

N Puizina-Ivić1, B Matoković, I Gluncić, S Maslovara, J Vela-Ljubić.   

Abstract

During the 6-year period (January 1, 1993 to December 31, 1998) in the Laboratory for Dermatopathology of Department of Dermatovenereology in Clinical Hospital Split, 1616 basal cell carcinomas (BCC) of a total of 323 investigated specimens were diagnosed. The incident rate varies from 92 to 114 BCC per 100,000 inhabitants in the Split region. The sex ratio in material is 1.2:1 in favor of males. The frequence of BCC increases with the advanced age in both sexes with the peak in the age group from 70 to 79 years. The most frequent location in both sexes is the nose followed by cheeks and trunk. Statistic analysis showed a significantly higher occurrence of BCC in temporal region in the males and perioral region in the females; respectively. The solid variant is the most frequent followed by superficial multicentric and solid-adenoid. Pure variants are found in 83.1% specimens, and mixed variants in 16.9%. Solid and adenoid variants are the most frequent on the nose and cheeks. According to statistics cystic variant is significantly higher on the forehead, and morpheic variant on the nose. Superficial multicentric variant is statistically more frequent on the trunk than on other locations. All specimens were reexamined and histopathologic variants were obtained. Over 2000 data are comprised which is a sufficient examination sample. In programs such as SPSS, and Graph master ver 1.12, Win95, MO'97 (Word, Excel, Access) on Pentium II 200 MHz, floppy, 64 MB RAM, HDD 2.1 GB, CD x24, HP LJet 6L, a comprehensive analysis has been performed.

Entities:  

Mesh:

Year:  1999        PMID: 10587919     DOI: 10.1023/a:1020533318323

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  17 in total

1.  Excision repair of pyrimidine dimers induced by simulated solar radiation in the skin of patients with basal cell carcinoma.

Authors:  J Alcalay; S E Freeman; L H Goldberg; J E Wolf
Journal:  J Invest Dermatol       Date:  1990-11       Impact factor: 8.551

2.  Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota.

Authors:  T Y Chuang; A Popescu; W P Su; C G Chute
Journal:  J Am Acad Dermatol       Date:  1990-03       Impact factor: 11.527

3.  Basal cell carcinoma in children.

Authors:  E B Milstone; E B Helwig
Journal:  Arch Dermatol       Date:  1973-10

4.  The many faces of basal-cell carcinoma.

Authors:  T R Wade; A B Ackerman
Journal:  J Dermatol Surg Oncol       Date:  1978-01

5.  The incidence of basal cell carcinoma in an area of Stockholm County during the period 1971-1980.

Authors:  P Wallberg; E Skog
Journal:  Acta Derm Venereol       Date:  1991       Impact factor: 4.437

6.  Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms.

Authors:  M Sexton; D B Jones; M E Maloney
Journal:  J Am Acad Dermatol       Date:  1990-12       Impact factor: 11.527

7.  The relative importance of risk factors in nonmelanoma carcinoma.

Authors:  P P Vitaliano; F Urbach
Journal:  Arch Dermatol       Date:  1980-04

8.  Incidence of non-melanoma skin cancer in West Glamorgan, South Wales.

Authors:  D L Roberts
Journal:  Br J Dermatol       Date:  1990-03       Impact factor: 9.302

9.  On the nature of susceptibility to cancer. The presidential address.

Authors:  D G Miller
Journal:  Cancer       Date:  1980-09-15       Impact factor: 6.860

Review 10.  Biology of basal cell carcinoma (Part I).

Authors:  S J Miller
Journal:  J Am Acad Dermatol       Date:  1991-01       Impact factor: 11.527

View more
  2 in total

Review 1.  Sex disparity in skin carcinogenesis and potential influence of sex hormones.

Authors:  V Collier; M Musicante; T Patel; F Liu-Smith
Journal:  Skin Health Dis       Date:  2021-04-01

2.  Histopathological evaluation of non-melanoma skin cancer.

Authors:  Ali Koyuncuer
Journal:  World J Surg Oncol       Date:  2014-05-21       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.